This encouraging result obtained on ALC or T cell counts led the Blay/Ray-Coquard team to further document CD4 T cell counts in various populations of cancer patients, including breast cancer, and to further explore the diversity of the TCR repertoire in collaboration with ImmunID Technologies. Here, CD4 is linked to cancer.